Leproust Emily M.'s Form 4 filing
Twist Bioscience Corp (TWST) · filed Nov 6, 2024
- Accession no.
- 0001214659-24-018500
- Filed
- Nov 6, 2024
- Trade date
- Nov 4, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $201.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Leproust Emily M.CIK 0001753655 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 4, 2024 | Common Stock | AGrant or awardAcquired | +80,855 | $0.00 | $0 | 562,773 | Direct | |
| Nov 4, 2024 | Common Stock | AGrant or awardAcquired | +45,954 | $0.00 | $0 | 608,727 | Direct | |
| Nov 4, 2024 | Common Stock | SSaleDisposed | −4,841 | $41.56 | −$201,191.96 | 603,886 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.